期刊文献+

c-Src介导的ERα与EGFR互作关系在乳腺癌三苯氧胺耐药中的作用 被引量:1

Role of c-Src mediated interactional relationship between ERα and EGFR in tamoxifen resistance of breast cancer
原文传递
导出
摘要 目的:探讨雌激素受体(ER)与表皮生长因子受体(EGFR)的关系及其在乳腺癌三苯氧胺(TAM)治疗耐药中的作用与机制。方法:选用TAM治疗敏感(TAM-S)与耐药(TAM-R)的两种人乳腺癌MCF-7细胞,用免疫沉淀(IP)法检测ERα和EGFR在两种细胞中的结合情况,以及c-Src与前两者的结合情况,并用Western blot法检测两种细胞中c-Src的磷酸化水平;c-Src阻滞剂PP2处理两种细胞后,IP法再次检测ERα和EGFR结合情况。结果:ERα和EGFR在两种细胞中均以复合物的形式结合,但在TAM-R细胞中的结合量明显高于TAM-S细胞(P<0.05);c-Src与ERα、EGFR在两种细胞中均以复合物的形式结合,其磷酸化水平在TAM-R细胞中明显高于TAM-S细胞(P<0.05);PP2阻断c-Src的活性后,两种细胞中ERα和EGFR结合量均降低,且在TAM-R细胞中的降低程度明显大于TAM-S细胞(P<0.05)。结论:ERα和EGFR之间存在结合的现象,且两者的互作关系可能在乳腺癌TAM治疗耐药中起了重要作用,而c-Src的活化(磷酸化)是可能是介导了两者结合的关键机制。 Objective: To investigate the relationship between estrogen receptor (ER) and epidermal growth factor receptor (EGFR), and its role and mechanism in tamoxifen (TAM) therapy resistance of breast cancer.Methods: Two types of cells namely the TAM therapy-sensitive (TAM-S) and -resistant (TAM-R) human breast cancer MCF-7 cells were used. In these two types of cells, immunoprecipitation (IP) was performed to detect the connection between ERα and EGFR, and the connection of c-Src to the two former receptors, and the phosphorylation level of c-Src was also determined by Western blot analysis. After treatment with c-Src inhibitor PP2, the connection between ERα and EGFR was examined again by IP method. Results: ERα and EGFR linked in a complex form in both types of cells, but the linkage level in TAM-R cells was significantly higher than that in TAM-S cells (P〈0.05). c-Src linked in a complex form to either ERα or EGFR in both types of cells, and the phosphorylation level of c-Src in TAM-R cells was significantly higher than that in TAM-S cells (P〈0.05). After the c-Src activity was inhibited by PP2, linkage level between ERα or EGFR was decreased in both types of cells, while the decreasing degree in TAM-R cells was significantly greater than that in TAM-S cells (P〈0.05).Conclusion: There is a connection between ERα and EGFR, which may play an important role in TAM therapy resistance of breast cancer, and c-Src activation (phosphorylation) may be the crucial mechanism for their linkage.
出处 《中国普通外科杂志》 CAS CSCD 北大核心 2014年第5期618-623,共6页 China Journal of General Surgery
基金 江苏省无锡市卫生局科研资助项目(XM1010)
关键词 乳腺肿瘤 雌激素受体Α 受体 表皮生长因子 原癌基因蛋白质pp60(c-Src) 他莫昔芬 抗药性 肿瘤 Breast Neoplasms Estrogen Receptor a Receptor, Epidermal Growth Factor Proto-Oncogene Proteins pp60(c-src) Tamoxifen Drug Resistance, Neoplasm
  • 相关文献

参考文献20

  • 1Palmieri C,Patten DK,Januszewski A,et al.Breast cancer:current and future endocrine therapies[J].Mol Cell Endocrinol,2014,382(1):695-723.
  • 2Osborne CK,Schiff R.Mechanisms of endocrine resistance in breast cancer[J].Annu Rev Med,2011,62:233-247.
  • 3Thrane S,Lykkesfeldt AE,Larsen MS,et al.Estrogen receptor c is the major driving factor for growth in tamoxifen-resistant breast cancer and supported by HER/ERK signaling[J].Breast Cancer Res Treat.2013.139(1):71-80.
  • 4Yang Z,Barnes C J,Kumar R.Human epidermal growth factor receptor 2 status modulates subcellular localization of and interaction with estrogen receptor alpha in breast cancer cells[J].Clin Cancer Res,2004,10(11):3621-3628.
  • 5胡浩,顾元龙,朱从元,黄阿雷,周燕娜,李建平.c-Src在TAM治疗耐药的人乳腺癌MCF-7细胞株中的表达及其意义[J].中国普通外科杂志,2013,22(5):629-632. 被引量:2
  • 6王秀玲,益莉娜,丁佩芬,邹珏,洪月琳,郑唯强.雌激素和三苯氧胺对MCF-7乳腺癌细胞Akt表达的影响及其意义[J].中国普通外科杂志,2007,16(12):1197-1199. 被引量:3
  • 7Mauro L,Pellegrino M,De Amicis F,et al.Evidences that estrogen receptor cL interferes with adiponectin effects on breast cancer cell growth[J].Cell Cycle,2014,13(4):553-64.
  • 8Meneses-Morales I,Tecalco-Cruz AC,Barrios-Garcia T,et al.SIP1/NHERF2 enhances estrogen receptor alpha transacfivation in breast cancer cells[J].Nucleic Acids Res,2014.[EDub ahead of Drintl.
  • 9Kalet BT,Anglin SR,Handschy A,et al.Transcription factor Ets1 cooperates with estrogen receptor c to stimulate estradiol-dependent growth in breast cancer ceils and tumors[J].PLoS One,2013,8(7):e68815.
  • 10Fenne IS,Helland T,Flgeng MH,et al.Downregulation of steroid receptor coactivator-2 modulates estrogen-responsive genes and stimulates proliferation of mcf-7 breast cancer cells[J].PLoS One,2013,8(7):e70096.

二级参考文献16

  • 1张伟,张军初,徐昕昀,朱大乔,何金,王强.维生素E琥珀酸酯对乳腺癌荷瘤裸鼠的抑瘤作用[J].中国普通外科杂志,2005,14(12):918-921. 被引量:3
  • 2申郑堂,罗沙阳,王守满,邬玉辉,欧慧英,海健.乳腺癌哨兵淋巴结转移与肿瘤大小和癌基因及激素受体表达关系的临床观察[J].中国普通外科杂志,2006,15(10):728-731. 被引量:10
  • 3Toker A, Yoeli-Lemer M. Akt signaling and cancer: surviving but not moving on[J]. Cancer Res, 2006,66(8) : 3963-3966.
  • 4Stambolic V, Woodgett JR. Functional distinctions of protein kinase B/Akt isoforms defined by their influence on cell migration [ J ] . Trends Cell Biol, 2006,16 ( 9 ) : 461 - 466.
  • 5Kirkegaard T, Witton C J, McGlynn LM, et al. AKT activation predicts outcome in breast cancer patients treated with tamoxifen[J]. J Pathol, 2005,207(2):139-146.
  • 6Cantley LC. The phosphoinositide 3-kinase pathway [ J ]. Science, 2002 , 296 ( 5573 ) : 1655 - 1657.
  • 7Nicholson KM, Anderson NG. The protein kinase B/Akt signalling pathway in human malignancy [ J ]. Cell Signal, 2002,14(5) :381 -395.
  • 8Gao N, Flynn DC, Zhang Z, et al. G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K/ AKT/MTOR/P70S6K1 signalling in human ovarian cancer cells[J]. Am J Physiol Cell Physiol, 2004, 287 (2) : C281 -291.
  • 9Arboleda M J, Lyons JF, Kabbinavar FF, et al. Overexpression of AKT2/protein kinase beta leads to up-regulation of beta 1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells [ J ] . Cancer Res, 2003 , 63 (1):196-206.
  • 10Tokunaga E, Kataoka A, Kirnura Y, et al, The association between Akt activation and resistance to hormone therapy in metastatic breast cancer [ J ]. Euro J Cancer, 2006, 42 (5) :629 -635.

共引文献3

同被引文献13

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部